Evaluation of the efficacy of traditional Chinese medicine on mild patients with COVID-19

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2022
INTERVENTION: experimental group:Symptomatic treatment of Western medicine + Jinghua Jiedu decoction;control group:Symptomatic treatment of Western medicine + Jinghua Jiedu decoction placebo; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Nucleic acid turning negative time;Nucleic acid conversion rate; SECONDARY OUTCOME: rate to the normal/heavy;Time/rate of the abatement of fever;Time/rate of clinical symptom remission;Cumulative incidence of adverse events; INCLUSION CRITERIA: 1. Patients with mild COVID‐19; 2. Aged 18‐80 years; 3. Voluntarily accept treatment and sign informed consent.
Epistemonikos ID: 44df7194698fc60c37098a8de602e9af79063e00
First added on: Nov 05, 2022